Sami-Sabinsa Group held a groundbreaking ceremony for its new $30 million Active Pharmaceutical Ingredients (API) manufacturing unit at Pharma SEZ Industrial Area, in Hassan, Karnataka.
The facility is part of the group’s strategy to expand existing ingredient growth and focus on innovative new products. The location marks Sami-Sabinsa's eighth manufacturing facility.
Prajwal Gowda, member of parliament in Hassan, and Preetham J. Gowda, member of the legislative assembly (MLA), graced the ceremony, along with the Sami-Sabinsa Group senior management team and employees of Sami Labs.
Covering 430,556 square feet of this API manufacturing unit, the first phase will have a production capacity of more than 300 tons per annum.
As an environmentally conscious, Zero Liquid Discharge (ZLD) facility, it will combine user comfort, energy efficiency, responsible water management and biodiversity development.
It will also be 100% cGMP and compliant with regulatory requirements and is scheduled for commissioning by 2021 and is expected to generate employment for approximately 400 people in and around Hassan.
“We have been doing business in India for nearly three decades now, and our business has grown rapidly over the years,” Muhammed Majeed, Ph.D., founder and chairman, Sami-Sabinsa Group, said. “The upcoming production facility at Hassan will not only empower us to cater to the entire global market with patented and off-patent API products but will also play a vital role in boosting the export sales of the Sami-Sabinsa Group and help in doubling the company revenue.”
